Skip to main content
Log in

Event Surrogate from Clinical Pathway Completion to Daily Meal for Availability Extension Using Standard Electronic Medical Records: a Retrospective Cohort Study

  • Systems-Level Quality Improvement
  • Published:
Journal of Medical Systems Aims and scope Submit manuscript

Abstract

This study aimed to improve generalizability of our previous study that analyzed clinical pathway (CP) completion. Although our previous study demonstrated that CP completion can reduce the length of hospital stay, it is possible for few medical organizations to extract the implementation of treatment registered on CP from typical electronic medical records. Therefore, we have defined a prospective event for event substitution, called meal completion (MC), in which patients can take their meal daily. Data were collected from April 2013 to March 2018 from the electronic medical records of the University of Miyazaki Hospital. We used propensity score matching to extract records from 8033 patients. Patients were further divided into the MC and non-MC groups; 2577 patients in each group were available for data analysis. The numbers of patients with CP completion were 646 (28.1%) in the MC group and 411 (18.2%) in the non-MC group. The P value of the chi-square test was <0.001. According to this result, there was the causation from MC to increase in CP completion. Additionally, it was possible to consider the inclusion relationship in all treatments (universal set), treatments registered on CP (subset of all treatments), and meals (subset of treatments registered on CP). In conclusion, MC can substitute for CP completion because the demonstration is appropriate for the Prentice criterion, which is often used for the evaluation of a surrogate endpoint.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Data availability

Not applicable.

References

  1. Kinsman L, Rotter T, James E, Snow P, Willis J (2010) What is a clinical pathway? Development of a definition to inform the debate. BMC Med 8:31. https://doi.org/10.1186/1741-7015-8-31.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Sanei-Moghaddam A, Ma T, Goughnour SL, Edwards RP, Lounder PJ, et al (2016) Changes in Hysterectomy Trends After the Implementation of a Clinical Pathway. Obstet Gynecol 127:139–147. https://doi.org/10.1097/AOG.0000000000001185.

    Article  PubMed  Google Scholar 

  3. Thursky K, Lingaratnam S, Jayarajan J, Haeusler GM, Teh B et al (2018) Implementation of a whole of hospital sepsis clinical pathway in a cancer hospital: impact on sepsis management, outcomes and costs. BMJ Open Qual 7:e000355. https://doi.org/10.1136/bmjoq-2018-000355.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Donà D, Zingarella S, Gastaldi A, Lundin R, Perilongo G et al (2018) Effects of clinical pathway implementation on antibiotic prescriptions for pediatric community-acquired pneumonia. PLoS One 13:e0193581. https://doi.org/10.1371/journal.pone.0193581.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Messing BP, Ward EC, Lazarus C, Ryniak K, Kim M et al (2019) Establishing a Multidisciplinary Head and Neck Clinical Pathway: An Implementation Evaluation and Audit of Dysphagia-Related Services and Outcomes. Dysphagia 34:89–104. https://doi.org/10.1007/s00455-018-9917-4.

    Article  PubMed  Google Scholar 

  6. Furuhata H, Araki K, Ogawa T, Ikeda M (2017) Effect on Completion of Clinical Pathway for Improving Clinical Indicator: Cases of Hospital Stay, Mortality Rate, and Comprehensive-Volume Ratio. J Med Syst 41:206. https://doi.org/10.1007/s10916-017-0857-6.

    Article  PubMed  Google Scholar 

  7. Furuhata H, Araki K, Ogawa T (2020) Causation between Pathway Completion and Reduced Hospital Stay in Patients with Lung Cancer: a Retrospective Cohort Study Using Propensity Score Matching. J Med Syst 44:105. https://doi.org/10.1007/s10916-020-01570-1.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Kanehira, T., Sugihara, T., Suzuki, M., Gofuku, A., Araki, K., Exploring Risk-Benefit Factors of Electronic Clinical Pathways Regarding Nursing Communication. In: Duffy V. (eds) Digital Human Modeling: Applications in Health, Safety, Ergonomics and Risk Management. DHM 2016. Lecture Notes in Computer Science, vol 9745. Springer, Cham. https://doi.org/10.1007/978-3-319-40247-5_43, (2016)

  9. Rock CL, Thomson C, Gansler T, Gapstur SM, McCullough ML et al (2020) American Cancer Society Guideline for Diet and Physical Activity for Cancer Prevention. CA Cancer J Clin 70:245-271. https://doi.org/10.3322/caac.21591.

    Article  PubMed  Google Scholar 

  10. Shepherd SJ, Gibson PR (2006) Fructose Malabsorption and Symptoms of Irritable Bowel Syndrome: Guidelines for Effective Dietary Management. J Am Diet Assoc 106:1631-1639. https://doi.org/10.1016/j.jada.2006.07.010.

    Article  PubMed  Google Scholar 

  11. Reynolds A, Mann J, Cummings J, Winter N, Mete E, Morenga LT (2019) Carbohydrate quality and human health: a series of systematic reviews and meta-analyses. Lancet 393:434–45. https://doi.org/10.1016/S0140-6736(18)31809-9.

    Article  CAS  PubMed  Google Scholar 

  12. Ahring K, Belanger-Quintana A, Dokoupil K, Ozel HG, Lammardo AM, et al (2009) Dietary management practices in phenylketonuria across European centres. Clin Nutr 28:231–236. https://doi.org/10.1016/j.clnu.2009.03.004.

    Article  CAS  PubMed  Google Scholar 

  13. Manuela Neuenschwander, Aurelie Ballon, Katharina S Weber, Teresa Norat, Dagfinn Aune et al (2019) Role of diet in type 2 diabetes incidence: umbrella review of meta-analyses of prospective observational studies. BMJ 365:l2368. https://doi.org/10.1136/bmj.l2368.

    Article  Google Scholar 

  14. Gibson PR, Shepherd SJ (2010) Evidence-based dietary management of functional gastrointestinal symptoms: The FODMAP approach. J Gastroenterol Hepatol 25:252–258. https://doi.org/10.1111/j.1440-1746.2009.06149.x.

    Article  PubMed  Google Scholar 

  15. Biomarkers Definitions Working Group (2001) Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework. Clin Pharmacol Ther 69:89-95.

    Article  Google Scholar 

  16. Prentice RL. (1989). Surrogate endpoints in clinical trials: Definition and operational criteria. Stat Med 8:431-440.

    Article  CAS  Google Scholar 

  17. Freedman, L. S., Graubard B.I. (1992) Statistical validation of intermediate endpoints for chronic diseases. Stat Med 11:167-178.

    Article  CAS  Google Scholar 

  18. Buyse M, Molenberghs G (1998) Criteria for the validation of surrogate endpoints in randomized experiments. Biometrics 54:1014-1029.

    Article  CAS  Google Scholar 

  19. Daniels MJ, Hughes MD (1997) Meta-analysis for the evaluation of potential surrogate markers. Stat Med 16:1965-1982.

    Article  CAS  Google Scholar 

  20. Frykholm P, Schindler E, Sumpelmann R, Walker R, Weiss M (2018) Preoperative fasting in children: review of existing guidelines and recent developments. Br J Anaesth 120:469-474. https://doi.org/10.1016/j.bja.2017.11.080.

    Article  CAS  PubMed  Google Scholar 

  21. Ferrari LR, Rooney FM, Rockoff MA (1999) Preoperative Fasting Practices in Pediatrics. Anesthesiology 90:978-980. https://doi.org/10.1097/00000542-199904000-00008.

    Article  CAS  PubMed  Google Scholar 

  22. Kallar SK, Everett LL (1993) Potential Risks and Preventive Measures for Pulmonary Aspiration: New Concepts in Preoperative Fasting Guidelines. Anesth Analg 77:171-182. https://doi.org/10.1213/00000539-199307000-00034.

    Article  CAS  PubMed  Google Scholar 

  23. Todd PE (2001) Reconciling Conflicting Evidence on the Performance of Propensity-Score Matching Methods. Am Econ Rev 91:112-118.

    Article  Google Scholar 

  24. Austin PC (2008) A critical appraisal of propensity-score matching in the medical literature between 1996 and 2003. Stat Med 27:2037-2049. https://doi.org/10.1002/sim.3150.

    Article  PubMed  Google Scholar 

  25. Lozano F, Ortiz A, Munilla J, Peinado A (2017) Automatic computation of regions of interest by robust principal component analysis. Application to automatic dementia diagnosis. Knowl-Based Syst 123:229-237. https://doi.org/10.1016/j.knosys.2017.02.025.

    Article  Google Scholar 

  26. Schafer I, Leitner EC, Schon G, Koller D, Hansen H et al (2010) Multimorbidity Patterns in the Elderly: A New Approach of Disease Clustering Identifies Complex Interrelations between Chronic Conditions. PLoS One 5(12):e15941. https://doi.org/10.1371/journal.pone.0015941.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Huo Z, Ding Y, Liu S, Oesterreich S, Tseng G (2016) Meta-Analytic Framework for Sparse K-Means to Identify Disease Subtypes in Multiple Transcriptomic Studies. J Am Stat Assoc 111:27-42. https://doi.org/10.1080/01621459.2015.1086354.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Chang D, Keinan A (2014) Principal Component Analysis Characterizes Shared Pathogenetics from Genome-Wide Association Studies. PLoS Comput Biol 10(9):e1003820. https://doi.org/10.1371/journal.pcbi.1003820.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

The authors would like to thank Enago (www.enago.jp) for the English language review.

Funding

There were no external funding sources for this study.

Author information

Authors and Affiliations

Authors

Contributions

Hiroki Furuhata: Conceptualization; data curation; formal analysis; Investigation; methodology; software; visualization; and writing – original draft.

Kenji Araki: Funding acquisition; project administration; resources; supervision; validation; and writing – review and editing.

Taisuke Ogawa: Data curation; validation; and writing – review and editing.

Corresponding author

Correspondence to Hiroki Furuhata.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethics approval

All procedures performed in studies involving human participants were in line with the ethical standards of the Committee of Medical Ethics, University of Miyazaki (ethics approval number, O-0383) and the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.

Consent to participate

Informed consent was obtained by an opt-out method. Concretely, the authors noted details of this study on their website and asked participants to offer the authors not to use their information until the specified date. After this date, the authors could use information without patients’ consent.

Consent for publication

Not applicable.

Code availability

Not applicable.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Systems-Level Quality Improvement

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Furuhata, H., Araki, K. & Ogawa, T. Event Surrogate from Clinical Pathway Completion to Daily Meal for Availability Extension Using Standard Electronic Medical Records: a Retrospective Cohort Study. J Med Syst 45, 33 (2021). https://doi.org/10.1007/s10916-021-01714-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s10916-021-01714-x

Keywords

Navigation